NEW YORK (Reuters Health) - Pregnant women with a history of pregnancy-related diabetes, also called gestational diabetes, have a good chance of developing the condition again, suggests a large new study.
NEW YORK (Reuters Health) - Children who live in damp, water-damaged homes may be more likely than other kids to develop nasal allergies, a new study suggests.
NEW YORK (Reuters Health) - When professional athletes in sports like football and rugby are injured, they commonly get injections of pain-numbing anesthetics to help them stay in the game. Now a new study suggests that, while safety concerns remain, most athletes may not suffer any long-term harm from the practice.
GENEVA (Reuters) - Eastern Africa is free of polio again, with four countries — Ethiopia, Kenya, Sudan and Uganda — having reported no cases of the crippling disease for more than a year, U.N. and other aid agencies said Friday.
HONG KONG (Reuters) - Calcium supplements, which many people consume hoping to ward off osteoporosis, may increase the risk of heart attack by as much as 30 percent, researchers reported Friday.
LONDON (Reuters) - An updated edition of a mental health bible for doctors may include diagnoses for “disorders” such as toddler tantrums and binge eating, experts say, and could mean that soon no-one will be classed as normal.
WASHINGTON (Reuters) - Rabbits implanted with artificial bones re-grew their own joints, complete with cartilage, researchers reported on Thursday.
HONG KONG (Reuters) - Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the standard drug for treating leukemia or cancer of the blood cells.
UNITED NATIONS (Reuters) - The U.N. General Assembly asserted a global right to water and sanitation in a resolution on Wednesday, but more than 40 countries abstained, saying no such right yet existed in international law.
NEW YORK (Reuters) - A decision by a U.S. appeals court could pave the way for cheaper generic forms of Eli Lilly and Co’s Gemzar cancer drug to be launched in the United States beginning in mid-November.